![[HTML version]](/e/graphics/htmlborder.gif)
![[PDF version]](/e/graphics/pdfborder.gif)
![[CIF]](/e/graphics/cifborder.gif)
![[3d view]](/e/graphics/3dviewborder.gif)
![[Structure Factors]](/e/graphics/structurefactorsborder.gif)
![[CIF check Report]](/e/graphics/checkcifborder.gif)
![[Buy article online]](/logos/buy.gif)
![[Contents scheme]](kp2089contents.gif)
Acta Cryst. (2007). E63, m988-m990 [ doi:10.1107/S1600536807009762 ]
Abstract: The title compound, [Cu(C15H4BF18N6)(C2H3N)] or [HB(3,5-(CF3)2Pz)3]CuI(CH3CN), was synthesized from [CuI(CF3SO3)]2·C6H5CH3 and [HB(3,5-(CF3)2Pz)3]Na(H2O) in CH2Cl2/CH3CN. The CuI atom adopts a distorted tetrahedral geometry and is coordinated by four N atoms, three N atoms from the tridentate tris(pyrazolyl)borate ligand [Cu-N = 2.0992 (12) Å] and one N atom from acetonitrile [Cu-N = 1.888 (3) Å]. The acetonitrile ligand is linear. The Cu atom, acetonitrile ligand, B and its attached H atom lie on a crystallographic threefold rotation axis.
Online 7 March 2007
Copyright © International Union of Crystallography
IUCr Webmaster